SA PRO
Free Account
Oscar Health, Inc.OSCRNYSE
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts are neutral — opinion is divided on direction.

Consensus Rating
Hold
10 analysts·Moderate coverage
20%
Rating Distribution
Strong Buy
00%
Buy
220%
Hold
660%
Sell
220%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 13% higher.

Bear Case
$13.00
-7%
Consensus
$15.80
+13%
Bull Case
$18.00
+29%
Price Range10 analysts
Low
Consensus
High
$13.00
$18.00
Current Target
Current Price
$14.00
Upside to Target
$1.80

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 9, 2026UBS
Oscar Health upgraded to Neutral from Sell at UBS
Target:$17.00
+0.6%from $16.90
Jan 5, 2026Barclays
Oscar Health upgraded to Equal Weight from Underweight at Barclays
Target:$18.00
+20.2%from $14.97
Oct 14, 2025Goldman Sachs
Oscar Health initiated with a Neutral at Goldman Sachs
Target:$17.00
-16.7%from $20.40
Oct 7, 2025Wells Fargo
Oscar Health price target raised to $14 from $10 at Wells Fargo
Target:$14.00
-37.2%from $22.31
Aug 14, 2025Piper Sandler
Oscar Health price target lowered to $13 from $14 at Piper Sandler
Target:$13.00
-11.2%from $14.64
Aug 8, 2024Piper Sandler
Oscar Health Inc (OSCR) PT Raised to $28 at Piper Sandler
Target:$28.00
+52.3%from $18.38
Jun 25, 2024Piper Sandler
Piper Sandler Starts Oscar Health Inc (OSCR) at Overweight
Target:$25.00
+41.7%from $17.64
Jun 12, 2024Wells Fargo
Oscar Health price target raised to $27 from $24 at Wells Fargo
Target:$27.00
+34.9%from $20.01
Jun 10, 2024Goldman Sachs
Goldman Sachs Reiterates Neutral Rating on Oscar Health Inc (OSCR)
Target:$21.00
+3.9%from $20.21
Mar 21, 2024Raymond James
Raymond James Starts Oscar Health Inc (OSCR) at Outperform
Target:$20.00
+45.3%from $13.76
Nov 15, 2022Wells Fargo
Oscar Health upgraded to Overweight from Equal Weight at Wells Fargo
Target:$4.00
+38.4%from $2.89
Nov 14, 2022Morgan Stanley
Morgan Stanley Downgrades Oscar Health to Equal-Weight, Lowers Price Target to $5
Target:$5.00
+69.5%from $2.95
Sep 1, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on Oscar Health, Lowers Price Target to $9
Target:$9.00
+48.9%from $6.04
Jun 9, 2022Morgan Stanley
Morgan Stanley Maintains Overweight on Oscar Health, Lowers Price Target to $12
Target:$12.00
+129.9%from $5.22

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance